H5N1 Avian Influenza: What You Need to Know. Wild Rumors and a Look Beyond the Usual Propaganda

All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name (desktop version)

To receive Global Research’s Daily Newsletter (selected articles), click here.

Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.



It looks like there is a concerted effort underway to prepare the public for a “new pandemic”, and here are some of the mainstream media headlines making the rounds this past week:

  • UK: “Bird flu HAS mutated to infect people…fresh pandemic fears” (click here)
  • USA: “CDC says it’s in a posture of readiness amid fears H5N1 bird flu is poised to jump to humans – there are several vaccines and drugs in the works” (click here)
  • China: “A 53 year old woman in eastern China has tested positive for H5N1 avian influenza, (clade, after exposure to poultry (click here)
  • UK: “Lateral flow tests being prepared for UK outbreaks of avian flu” (click here)
  • Peru: “At least 3500 sea lions in Peru have recently died of H5N1 bird flu” (click here)
  • Cambodia: “Young girl dies of H5N1 bird flu in Cambodia” (click here)
  • Argentina & Uruguay: “Last week, Argentina and Uruguay declared national health emergencies following outbreaks of highly pathogenic avian influenza H5N1” (click here)
  • USA New York Times: “An even deadlier pandemic could soon be here” (click here)

What is H5N1 influenza? CDC experts tell us (click here):

  • Current clade of H5N1 avian influenza is called, appears well adapted to spread efficiently among wild birds and poultry, was first identified in wild birds in the US in late 2021, and has affected 58 million commercial poultry
  • Mammals: recent H5N1 infections in wild foxes & skunks in Canada and US, minks in Spain, and sea lions in Peru
  • CDC recently produced an H5 candidate vaccine virus that can be used to make an H5N1 vaccine and has shared it with vaccine manufacturers

“Case Fatality Rate of 56% in humans”

This is where the fear tactics and propaganda come in.

“In October 2022, the disease began spreading among minks at a mink farm in Spain, marking the first time the virus mutated to favor mammal-to-mammal transmission, according to Science.”

when humans have been infected by animals, the virus is deadly, as 56% of the reported cases in humans ended in fatality, according to the World Health Organization.” (click here)

“while the World Health Organization (WHO) reports that the mortality rate of avian flu in humans is around 56 percent, many experts believe it’s likely to be much lower if the virus becomes more transmissible. One reason avian flu is so lethal is that it infects the lower respiratory tract, which can lead to respiratory failure” (click here)

Here’s how a human bird flu pandemic could unfold

“If a human-transmissible version of H5N1 does emerge, there is a good chance that it would rapidly spread, as most people have no immunity to this subtype of flu, which could potentially result in a new pandemic.” (click here)

“A pandemic of H5N1 with a 53 per cent fatality rate would be unimaginable; however, some studies have suggested that when the virus switches hosts and adapts to mammals the lethality drops down significantly”

“we have two antivirals that would likely offer some benefit against H5N1 infection and there are several licensed H5N1 vaccines”

“Unfortunately, just like with SARS-CoV-2, the virus keeps evolving and so our existing H5N1 vaccines may not offer robust protection against the current versions of H5N1, though studies suggest they may still work very well and they also give us a very good starting point for making updated versions of the vaccines.

“WHO-affiliated labs already hold two flu virus strains that are closely related to the circulating H5N1 virus, which could be used by vaccine manufacturers to create a human vaccine if needed” – the second was added this past week to “more closely match the virus spreading among animals” (click here)

H5N1 Gain of Function Research resumed in 2019

H5N1 influenza virus research was temporarily ceased in January 2012 due to the risks involved with disseminating experimental results that could be used for nefarious purposes.” (click here)

“All research on H5N1 transmission was halted (in 2012) after laboratories at the University of Wisconsin and the Dutch Eramus Medical Center in Rotterdam, Netherlands created mutant forms that could be transmitted directly among ferrets.This was concerning because viruses that are easily transmissible between ferrets are often also easily transmissible between humans.”

H5N1 Gain of Function Research resumed in 2019 (click here)

The H5N1 Wild Rumors…Chris Sky

Chris Sky, who had successful predictions about COVID-19, lockdowns and ineffectiveness of mRNA vaccines in 2020 (click here), put out a video today claiming Chile is having an H5N1 outbreak and will be the first country to sign onto the new WHO Pandemic Treaty (click here).

Chris Sky also put out another video on Feb.28, 2023 claiming that a pilot informed him that two antivirals (Oseltamivir – Tamiflu, Peramivir) are being shipped in large quantities to USA, UK, Australia and Netherlands (click here). He included the following communication:

More H5N1 Rumors in Chile…

“Speculations are adrift that certain clandestine vaccine clinical trials are now being conducted in the vicinity due to an undisclosed outbreak of H5N1 Avian Flu virus affecting many healthy young men in a military camp” (click here)

“During January & February 2023, when carcasses of dead birds and other wild animals were being found in large quantities alongside beaches, besides health personnel, local authorities also used young military trainees to help clear the areas and dispose the animals”

“By late February 2023, news emerged that 25 first year trainees from the military school in Pichicuy commune, in Valparaiso Region had developed acute respiratory illness”

“Subsequent news reported that 12 of these military cadets remain in serious hospitalized condition”

“Chilean health and defense authorities ordered a news blackout but locals and parents on social media posted that more than 67 young cadets were seriously sick

“The WHO sent teams along with officials from US CDC and NIH to assist”

Reports have emerged that all military personnel are now receiving some kind of vaccine shots

H5N1 – timing of outbreak with WHO Pandemic Treaty

The propaganda is really ramping up and we have all the components of the next planned pandemic. This time, it is an H5N1 avian flu with an alleged 50% fatality rate, jumping between mammals, with a few human deaths already. The stage is set with antiviral medications and H5N1 vaccines ready to go.

There is an interesting focus on South America, with Peru, Argentina and Uruguay having H5N1 outbreaks in poultry and mammals. Chris Sky’s rumor centers on Chile. While it’s difficult to verify what is going on in Chile, the rumors about military cadets getting sick, are very interesting.

Dr.Robert Malone has recently warned about a new WHO Pandemic Treaty which would give the WHO complete power over US pandemic response (click here)

UK MP Andrew Bridgen has recently blasted the proposed WHO pandemic treaty as well (click here).

WHO Director Dr.Tedros Ghebreyesus has recently announced: “Next week countries will begin negotiations on a zero draft of the new (WHO) Pandemic Accord” (click here)

Kyle Becker reports that “Biden administration is reportedly poised to sign onto a WHO pandemic treaty.” (click here)

H5N1 antiviral Drugs and neuropsychiatric side effects

There are two classes of antiviral drugs used for the treatment of influenza: M2 ion-channel blockers amantadine and rimantadine which act against influenza A only (not recommended due to widespread natural resistance to those drugs among H1N1 and H3N2 influenza viruses), and neuraminidase enzyme inhibitors which act against influenza A and B.

Oseltamivir (Tamiflu), Peramivir (Rapivab) and Zanamivir (Relenza) are neuraminidase enzyme inhibitors.

Viral neuraminidases are essential for influenza reproduction, facilitating viral budding and release of replicated virus from infected host cells.

Oseltamivir (Tamiflu) and Zanamivir (Relenza) have already been used to treat H1N1 and H3N2 influenza infections and act by inhibiting the release of replicated virus from infected cells.

(Image source)

“Despite demonstration of limited benefit, the drug is widely used, with a total of 48 million patients receiving prescriptions for oseltamivir worldwide since 2006. Approximately 10% of the drug penetrates the blood-brain barrier, which allows for potential neuropsychiatric side effects” (click here)

The majority of these adverse events have been observed to have occurred in the pediatric population. Neuropsychiatric adverse events include delirium, disturbances in consciousness, perceptual changes, delusions, tremors, anxiety symptoms, seizure disorders, parasomnias, and apocrine and eccrine gland disorders

“Researchers have found increased propensity for mice to jump from 20-cm high platforms when given oseltamivir.”

“Japan contraindicated its use among individuals aged 10 to 19 due to concerns of abnormal behaviors”

Children receiving oseltamivir should be monitored for neuropsychiatric side effects

From a paper titled: “The Tamiflu fiasco and lessons learnt” (click here):

“Serious Adverse Events, especially neuropsychiatric events associated with Tamiflustarted getting reported…recent articles have questioned the risk-benefit ratio of the drug…recommendations for stockpiling the drug as given by WHO have been put to scrutiny…many reviewers have labeled Tamiflu saga as a “costly mistake.”

For those looking for safer alternatives (these were also helpful with COVID-19):

My Take…

H5N1 could well be the next planned pandemic. The mainstream media are pushing it hard now and we could see it “launched” in the coming weeks. If it hits, it’s going to be a “shock and awe” type of event, meant to catch people off guard.

We’ve been told that the next pandemic would get our attention. An H5N1 avian flu pandemic with a Case Fatality Rate of 56% would fit the bill.

The timing is particularly interesting.

With a new pandemic, the US Public Health Emergency will not end on May 11, 2023 as planned, and we may see the WHO fast-track their new WHO Pandemic Treaty, drafts of which are already being discussed by various countries (click here).

It would take the fear of H5N1’s 50% fatality rate for the public to accept bringing back mandatory masking and perhaps even lockdowns.

Public Health Authorities are likely to lead any H5N1 response with antivirals such as Oseltamivir (Tamiflu), Peramivir (Rapivab) or Zanamivir (Relenza), because H5N1 vaccines won’t be ready right away.

For me, one of the most interesting aspects of all this, is that once these antivirals are rolled out, all COVID-19 mRNA vaccine neurological injuries can then be blamed on the antivirals, as they have very similar, well known neuropsychiatric adverse events.

There will probably be a well-funded campaign to “rehabilitate” the reputation of mRNA vaccines, with Moderna CEO Stephane Bancel having already promised he can have any new mRNA vaccine brought to market in less than 6 months.

Imagine a situation where the public is begging for a new mRNA vaccine. It seems unthinkable right now with the tsunami of COVID-19 mRNA vaccine injuries & deaths, but introduce H5N1 with 50% fatality rate and not enough antiviral medications to go around, and the public will once again demand mRNA.

Imagine the public begging for lockdowns, with the government graciously offering financial support and perhaps even a Universal Basic Income, tied to a digital ID.

As we saw in 2020, the world can change very quickly when a new threat is on the horizon.


Note to readers: Please click the share buttons above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Dr. William Makis is a Canadian physician with expertise in Radiology, Oncology and Immunology. Governor General’s Medal, University of Toronto Scholar. Author of 100+ peer-reviewed medical publications.

All images in this article are from the author unless otherwise stated

Articles by: Dr. William Makis

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]